Current pharmacologic therapies and emerging alternatives in the treatment of ulcerative colitis

Digestion
Tetsuya NakamuraMamoru Watanabe

Abstract

Recent progress in both basic and clinical research has led us to develop sophisticated and effective medical therapy of ulcerative colitis (UC). Although classical agents such as aminosalicylates, corticosteroids and immunomodulatory drugs have remained as the gold standard for decades, their novel formulations and/or dosage regimens have changed their placements in the medical management of UC. In addition, studies have shown that a number of novel therapeutic agents, designed to target specific mechanisms involved in the inflammatory cascade, have efficacy for the treatment of UC and they will have significant clinical impacts in the near future. A clear understanding of the proven and potential benefits of both the standard and emerging therapies will be required for the optimum individual care of patients with varied clinical presentations.

References

Jul 4, 1992·BMJ : British Medical Journal·A B HawthorneJ E Lennard-Jones
Nov 1, 1985·Gastroenterology·G JärnerotH Sandberg-Gertzén
Dec 14, 1974·British Medical Journal·D P Jewell, S C Truelove
Jun 1, 1995·Journal of Clinical Gastroenterology·J SantosJ R Malagelada
Jun 30, 1994·The New England Journal of Medicine·S LichtigerS Hanauer
Oct 1, 1995·Alimentary Pharmacology & Therapeutics·M LémannR Modigliani
Jul 1, 1997·Journal of Clinical Gastroenterology·S ArdizzoneF Molteni
Jun 11, 1999·The American Journal of Gastroenterology·R D CohenS B Hanauer
Oct 9, 2002·Current Pharmaceutical Design·Suhasini IyerRoland Buelow
Dec 14, 2002·Inflammatory Bowel Diseases·Klaus FellermannEduard F Stange
Jan 25, 2003·The American Journal of Medicine·Sunanda KaneStephen Hanauer
Aug 28, 2003·Alimentary Pharmacology & Therapeutics·C HögenauerW Petritsch
Jan 23, 1965·Lancet·J E LENNARD-JONESF A JONES
Mar 16, 2004·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Hiroyuki HanaiIngvar Bjarnason
Aug 13, 2004·Gut·M J CarterUNKNOWN IBD Section, British Society of Gastroenterology
May 4, 2005·Inflammatory Bowel Diseases·Cosimo PranteraMassimo Campieri
Jun 17, 2005·The New England Journal of Medicine·Brian G FeaganMargaret K Vandervoort
Jul 27, 2005·Inflammatory Bowel Diseases·Simon TravisUNKNOWN RDP Investigators Study Group
Dec 13, 2005·The New England Journal of Medicine·Paul RutgeertsJean Frédéric Colombel
Feb 28, 2006·Journal of Gastroenterology·Toshifumi Hibi, Haruhiko Ogata
May 4, 2006·Alimentary Pharmacology & Therapeutics·T J CreedUNKNOWN BASBUC INVESTIGATORS
Aug 24, 2006·Digestive Diseases and Sciences·Martin H HoltmannMarkus F Neurath
Jan 24, 2007·Gastroenterology·Stefan SchreiberStephen B Hanauer
Jul 27, 2007·Nature·R J Xavier, D K Podolsky

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Related Papers

Current Gastroenterology Reports
Andrew S Ross, Russell D Cohen
Medicinal Research Reviews
Silvio DaneseRenzo Caprilli
American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
William N Tindall
The American Journal of Gastroenterology
M Robinson
© 2021 Meta ULC. All rights reserved